A new University of Gothenburg study has paved the way for the first drug treatment for sleep apnea. Compared to before receiving the treatment, breathing pauses decreased with on average more than 20 per hour for patients given the drug.

The treatment that has been tested is carbonic anhydrase (CA) inhibition, CA being an enzyme that serves to maintain a balance between carbonic acid and carbon dioxide in the body. Several drugs with CA inhibitory properties are already available on the market, and used for treatment of glaucoma, epilepsy and other disorders.

Previous research has not systematically tested whether CA inhibitors also might be used to treat obstructive sleep apnea. The current study was a randomized double-blind clinical trial, and 59 patients with moderate or severe sleep apnea completed it. Patients were randomly assigned to two groups receiving either 400 or 200 mg of the CA inhibitor, and a third group (the control group) that received placebo. The study lasted for four weeks.

Fewer breathing pauses

The results show that, overall, the treatment reduced the number of breathing pauses and promoted oxygenation during the night. A few patients experienced side effects, such as headache and breathlessness, which were more common in those receiving the highest dose.

The study results together with established safety data of the drug sulthiame provide support for continued research on CA inhibition as a new potential treatment for obstructive sleep apnea.

“Among the patients who received the higher dosage of the drug, the number of breathing pauses decreased by approximately 20 per hour. For just over a third of patients in the study, only half of their breathing pauses were left, and in one in five the number fell by at least 60 percent,” says Jan Hedner, Professor of Pulmonary Medicine.

The fact that several approved drugs in the CA inhibitor category are available on the market makes fast-tracking development of an approved drug for sleep apnea practicable. The drug used in this clinical trial was sulthiame, which is sometimes used to treat epilepsy in children.

Treatment options needed

Today, treatment for a patient with sleep apnea is either an oral appliance therapy or a CPAP (Continuous Positive Airway Pressure) mask. Both help to  maintain airway patency during sleep.

“These therapy options take time to get used to and, since they frequently are perceived as intrusive or bulky. Insufficient user time is therefore common. If we develop an effective drug, it will therefore make life easier for many patients and, in the long run, potentially also save more lives,” says Ludger Grote, Senior Lecturer at Sahlgrenska Academy, University of Gothenburg.

The German pharmaceutical company Desitin Arzneimittel GmbH funded the trial, and the results are published in the American Journal of Respiratory and Critical Care Medicine.

• 
  Duncan NRI at Texas Children’s Hospital Accelerates Neurological Research and Therapies with Historic $10M Gift from The Blue Bird Circle
  HOUSTON /PRNewswire/ — The Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children’s Hospital today announced it received a $10 million donation from The Blue Bird Circle. The Duncan NRI is a multidisciplinary group of 30+ physicians and scientists from Baylor College of Medicine working together to accelerate life-saving research and to develop effective therapies for the… Read more: Duncan NRI at Texas Children’s Hospital Accelerates Neurological Research and Therapies with Historic $10M Gift from The Blue Bird Circle
• 
  La Importancia de las Vacunas Regulares para la Salud Cardíaca
  (Family Features) Si bien la mayoría de los padres son buenos para hacer un seguimiento de las vacunas que sus hijos necesitan para mantenerse saludables, muchos adultos no se dan cuenta de que las vacunas también son importantes para mantenerse saludables para el corazón. Los adultos, especialmente aquellos con antecedentes de enfermedad cardíaca o ataque… Read more: La Importancia de las Vacunas Regulares para la Salud Cardíaca
• 
  As health problems stack up, so do serious financial woes, study shows
  Being in “poor health” is far more than just a saying, according to a new University of Michigan study.
• 
  FOUNDATION FOR SARCOIDOSIS RESEARCH LAUNCHES ITS FIRST-EVER CLINICAL TRIAL EQUITY INITIATIVE FOR BLACK AND AFRICAN AMERICANS
  The Ignore No More: ACTe Now! Campaign to address vast health disparities by seeking more inclusive approach to recruiting Black American patients for clinical trials and research CHICAGO — The Foundation for Sarcoidosis Research (FSR) is proud to announce the launch of the Ignore No More: ACTe Now! (Advance Clinical Trials for Equity in Sarcoidosis) campaign. The… Read more: FOUNDATION FOR SARCOIDOSIS RESEARCH LAUNCHES ITS FIRST-EVER CLINICAL TRIAL EQUITY INITIATIVE FOR BLACK AND AFRICAN AMERICANS
• 
  
  Relationships: Can Someone Fear Human Contact If They Had An Intrusive Caregiver?
  One thing that someone could often struggle with is feeling alone and isolated from others. During this time, they could be desperate for human contact and hope that they will soon spend time with another or a few others. However, if this was to take place, it doesn’t mean that their whole being would show… Read more: <br>Relationships: Can Someone Fear Human Contact If They Had An Intrusive Caregiver?